Lange Kai Henrik Wiborg, Larsson Benny, Flyvbjerg Allan, Dall Rolf, Bennekou Morten, Rasmussen Michael Højby, Ørskov Hans, Kjaer Michael
Sports Medicine Research Unit, Building 8, Bispebjerg Hospital, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.
J Clin Endocrinol Metab. 2002 Nov;87(11):4966-75. doi: 10.1210/jc.2001-011797.
We studied the acute effects of a single, sc GH dose on exercise performance and metabolism during bicycling. Seven highly trained men [age, 26 +/- 1 yr (mean +/- SEM); weight, 77 +/- 3 kg; maximal oxygen uptake, 65 +/- 1 ml O(2).min(-1).kg(-1)] performed 90 min of bicycling 4 h after receiving 7.5 IU (2.5 mg) GH or placebo in a randomized, double-blinded, cross-over design trial. A standardized pre-exercise meal was given 2 h before exercise. Blood was sampled at rest and during exercise and analyzed for GH, IGF-I, glucose, lactate, insulin, glycerol, and nonesterified fatty acids (NEFA). In the placebo trial, all subjects completed the exercise protocol without any difficulties. In contrast, two subjects were not able to complete the exercise protocol in the GH trial, and one subject barely managed to complete the protocol. In addition, GH administration resulted in exaggerated increases in plasma lactate concentrations during exercise (P < 0.0001). The combined lipolytic effect of GH and exercise, evidenced by increased plasma glycerol and serum NEFA concentrations, was 3-fold greater than the effect of exercise alone (P < 0.0001), but this increased substrate availability did not result in increased whole body fat oxidation (indirect calorimetry). Plasma glucose was, on average, 9% higher during exercise after GH administration compared with placebo (P < 0.0001). We conclude that a single, relevant GH dose causes exaggerated increases in plasma lactate and glycerol as well as serum NEFA during 90 min of subsequent bicycling at moderate to high intensity. The exaggerated increase in plasma lactate may be associated with substantially decreased exercise performance.
我们研究了单次皮下注射生长激素(GH)剂量对骑行运动表现和代谢的急性影响。七名训练有素的男性[年龄,26±1岁(平均值±标准误);体重,77±3千克;最大摄氧量,65±1毫升O₂·分钟⁻¹·千克⁻¹]在随机、双盲、交叉设计试验中接受7.5国际单位(2.5毫克)GH或安慰剂4小时后进行90分钟的骑行。在运动前2小时给予标准化的运动前餐。在静息和运动期间采集血液,分析其中的GH、胰岛素样生长因子-I(IGF-I)、葡萄糖、乳酸、胰岛素、甘油和非酯化脂肪酸(NEFA)。在安慰剂试验中,所有受试者均顺利完成运动方案。相比之下,在GH试验中有两名受试者无法完成运动方案,一名受试者勉强完成了方案。此外,给予GH导致运动期间血浆乳酸浓度过度升高(P<0.0001)。GH和运动联合产生的脂解作用,表现为血浆甘油和血清NEFA浓度升高,比单独运动的作用大3倍(P<0.0001),但这种底物可用性的增加并未导致全身脂肪氧化增加(间接测热法)。与安慰剂相比,给予GH后运动期间血浆葡萄糖平均高出9%(P<0.0001)。我们得出结论,单次给予相关剂量的GH会导致在随后90分钟的中高强度骑行期间血浆乳酸、甘油以及血清NEFA过度升高。血浆乳酸的过度升高可能与运动表现大幅下降有关。